Home / Health / GLP-1 Drugs May Slow Aging Process
GLP-1 Drugs May Slow Aging Process
13 Jun
Summary
- GLP-1 medications may slow biological aging at a cellular level.
- Study found GLP-1s slowed aging in 42% of HIV patients.
- Researchers aim for larger trials to confirm anti-aging effects.
A recent study from the University of California at San Diego indicates that GLP-1 medications, commonly used for weight loss and managing conditions like diabetes and cardiovascular disease, may also slow the rate of biological aging. The research suggests these drugs could be reprogramming cells to enhance immune function and decrease inflammation.
These cellular changes may contribute to a slower decline in the body. The study observed that GLP-1s slowed biological aging in 42 percent of participants living with HIV and steatotic liver disease. This finding emerged from a 32-week trial involving over 100 adults.
Scientists noted that many aging processes studied in individuals with HIV are also relevant to the general population. The UC San Diego team plans to conduct larger trials to validate these results and explore the duration of this effect. They also intend to investigate if combining GLP-1 therapies with healthy lifestyle choices could further enhance these benefits.
